Trials / Unknown
UnknownNCT02176109
Metabolism Des LAM
Rôle Pronostique Des métabolismes du Stress Oxydatif et du Fer Dans Les Leucémies Aiguës Myéloblastiques
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the investigators study the prognostic role of oxidative stress metabolism and iron in Acute myeloid leukemia.
Detailed description
Primary goal of this study is to Evaluate the characteristics of regulatory networks of iron and redox balance in leukemic cells, to study the correlations between the prognosis of AML patients (in terms of response to induction chemotherapy and survival i) and metabolism of these markers. Secondary ones areto assess the impact of induction therapy on markers of oxidative stress and to correlate biological iron and redox metabolism with the molecular status of patients (eg Flt3/IDH/CEBPA/NPM...). Eligibility criteria are patients at diagnostic of de novo acute myeloid leukemia (promyelocytic excluded) aged from 18 to 100 years.
Conditions
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2015-06-01
- Completion
- 2018-06-01
- First posted
- 2014-06-26
- Last updated
- 2014-06-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02176109. Inclusion in this directory is not an endorsement.